INVESTMENT
The SICC Innvierte of CDTI Innovation invests together with several co-investors in Orikine Bio, a company that develops a new generation of therapies for autoimmune, inflammatory and oncological diseases
The CDTI Innovation has committed an investment of 2.7 million euros in this company
Ver sección
The SICC Innvierte of CDTI Innovation invests together with Swanlaab Tech Fund II in PADMI, the leading paddle app in AI analysis, which improves the experience of players and clubs
The CDTI Innovation has committed an investment of 810,000 euros in this company
Ver sección
The CDTI Innovation formalizes the first investment of the Innvierte Deep-Tech & Tech Transfer fund with 30 million euros for pediatric health
Deep-Tech & Tech Transfer is a venture capital financial instrument that supports the ecosystem of technology transfer and deep-tech in Spain
Ver sección
The SICC Innvierte of the CDTI Innovation invests together with Orza Gestión y Tenencia de Patrimonios AIE and Kutxa Fundazioa, in Polymerbio, an innovative company that manufactures biodegradable medical devices
The CDTI Innovation has committed an investment of 450,000 euros in this company
Ver sección
CDTI Innovation’s SICC Innvierte invests in bound4blue, a leading company in wind propulsion systems that accelerate the decarbonization of the maritime sector
The CDTI Innovation has committed an investment of more than 17 million euros in this company
Ver sección
The CDTI Innovation, through Innvierte, approves 24 new co-investments and participate in 6 investment vehicles, with a commitment of about 323 million euros
The investment commitment by CDTI Innovation in the last four months is about 323 million euros
Ver sección
The CDTI SICC Innvierte of Innovation invests together with Bullnet Capital in 2EyesVision, innovative company ophthalmic technology
The contribution of CDTI committed Innovation in this endeavour is a total of eur 3 million
Ver sección
The CDTI SICC Innvierte of investing in Innovation Ingelia, together with two coinversores, to develop a technology to manage any residues biomass hydrochar, producing a sustainable and high-quality
The contribution of CDTI Innovation in this endeavour is a total of €2.718.000
Ver sección
The CDTI SICC Innvierte of investing in Innovation ARTHEx Biotech, together with Invivo Ventures, F.C.R. and Columbus Life Sciences Fund III, F.C.R., to develop a new treatment of RNA for myotonic dystrophy
The CDTI Innovation brings in this operation over eur 4 million
Ver sección
Subscribe to INVESTMENT